Related by context. Frequent words. (Click for all words.) 71 sustained virologic response 62 annualized relapse 61 PROMACTA 61 cytogenetic response 60 peginterferon 58 tumor recurrence 57 Bevacizumab 57 FOLFIRI 57 peginterferon alfa 2a 57 plus prednisone 57 candesartan 57 vandetanib 56 LMWH 56 disease progression 56 peg IFN 56 metastatic renal cell carcinoma 56 adalimumab 56 dacarbazine 55 HBV infection 55 Torisel 55 anakinra 55 limiting toxicity 55 nilotinib 55 pegylated interferon 55 neoadjuvant chemotherapy 55 Imatinib 55 Monotherapy 55 antiplatelet therapy 55 TORISEL 55 degarelix 55 bone metastasis 55 thromboembolic events 55 microalbuminuria 55 infliximab 55 peginterferon alfa 2b 55 seroconversion 54 imatinib 54 PegIntron 54 nonresponders 54 mg BID 54 mitoxantrone 54 dabigatran etexilate 54 nitazoxanide 54 sunitinib 54 RECIST criteria 54 topotecan 54 COPAXONE R 54 placebo p = 54 dasatinib 54 composite endpoint 54 Secondary endpoints 54 perindopril 53 IU mL 53 bosentan 53 imetelstat 53 entecavir 53 adefovir 53 decitabine 53 tamsulosin 53 free survival PFS 53 plus methotrexate 53 hypomagnesemia 53 hepatotoxicity 53 axitinib 53 chronic HCV infection 53 active comparator 53 mcg kg 53 azathioprine 53 zoledronic acid 53 tamoxifen therapy 53 SCH # 53 Secondary endpoints included 53 SUTENT 53 vicriviroc 53 tocilizumab 53 evaluable patients 53 unfractionated heparin 53 #mg dose [003] 53 biologic therapy 53 glomerular filtration rate 53 cardiovascular morbidity 53 secondary endpoint 53 plus ribavirin 53 raltegravir 53 stent implantation 53 HCV RNA 53 FOLFOX 53 HGS ETR1 53 undetectable viral load 53 temsirolimus 52 valopicitabine 52 prespecified 52 Secondary endpoints include 52 Cetuximab 52 anastrozole 52 angiotensin converting enzyme ACE 52 thrombotic events 52 gastrointestinal stromal tumors 52 XGEVA 52 Sorafenib 52 natalizumab